Merck's COVID Pill Cuts Hospitalisations By 50%
United States (US) pharmaceutical company Merck said Friday it will seek authorization of its oral drug molnupiravir for COVID-19 after it was shown to reduce the chance newly infected patients were hospitalised by 50 percent.A simple pill to treat the coronavirus has been sought since the start of the pandemic and Friday's announcement was hailed as a major step towards that goal."We are optimistic that molnupiravir can become an important medicine as part of the global effort to f